Clinical Trial Update: Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating alpha-lipoic acid for non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED